{"id":"https://openalex.org/W2279314616","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3547","title":"Combination of 5-azacytidine (5-AZA) and valproic acid (VPA) in advanced solid cancers: A phase I study","display_name":"Combination of 5-azacytidine (5-AZA) and valproic acid (VPA) in advanced solid cancers: A phase I study","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2279314616","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3547","mag":"2279314616"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.3547","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3547","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.3547","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103523185","display_name":"Andres O. Soriano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. O. Soriano","raw_affiliation_strings":["MD Anderson Cancer Ctr, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Ctr, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104666966","display_name":"Fadi Braiteh","orcid":"https://orcid.org/0000-0003-2051-3893","observed_orcids":["https://orcid.org/0000-0003-2051-3893"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Braiteh","raw_affiliation_strings":["MD Anderson Cancer Ctr, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Ctr, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Garcia-Manero","raw_affiliation_strings":["MD Anderson Cancer Ctr, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Ctr, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022436659","display_name":"Luis H. Camacho","orcid":"https://orcid.org/0000-0003-1856-8641","observed_orcids":["https://orcid.org/0000-0003-1856-8641"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. H. Camacho","raw_affiliation_strings":["MD Anderson Cancer Ctr, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Ctr, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026095888","display_name":"David S. Hong","orcid":"https://orcid.org/0000-0001-8721-1609","observed_orcids":["https://orcid.org/0000-0001-8721-1609"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Hong","raw_affiliation_strings":["MD Anderson Cancer Ctr, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Ctr, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102972148","display_name":"Stacy Moulder","orcid":"https://orcid.org/0000-0001-8890-7077","observed_orcids":["https://orcid.org/0000-0001-8890-7077"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Moulder","raw_affiliation_strings":["MD Anderson Cancer Ctr, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Ctr, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053460346","display_name":"Chaan S. Ng","orcid":"https://orcid.org/0000-0001-9261-7021","observed_orcids":["https://orcid.org/0000-0001-9261-7021"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Ng","raw_affiliation_strings":["MD Anderson Cancer Ctr, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Ctr, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Kurzrock","raw_affiliation_strings":["MD Anderson Cancer Ctr, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Ctr, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"3547","last_page":"3547"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.11050000041723251,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.906000018119812},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":1.0},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.8450000286102295},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6489999890327454},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9679999947547913},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7609999775886536},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9340000152587891},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9020000100135803},{"id":"https://openalex.org/keywords/global-dna-methylation","display_name":"global DNA methylation","score":0.9120000004768372},{"id":"https://openalex.org/keywords/histone-acetylation","display_name":"histone acetylation","score":0.8539999723434448},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.7210000157356262},{"id":"https://openalex.org/keywords/uveal-melanoma","display_name":"uveal melanoma","score":0.8399999737739563},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.5419999957084656},{"id":"https://openalex.org/keywords/leiomyosarcoma","display_name":"leiomyosarcoma","score":0.5870000123977661},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8221279382705688},{"id":"https://openalex.org/C2777172819","wikidata":"https://www.wikidata.org/wiki/Q240642","display_name":"Valproic Acid","level":3,"score":0.5611598491668701},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5196055769920349},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5124859809875488},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.5060457587242126},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.50079345703125},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.4946107566356659},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4920794367790222},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47925853729248047},{"id":"https://openalex.org/C2779277951","wikidata":"https://www.wikidata.org/wiki/Q5255196","display_name":"Demethylating agent","level":5,"score":0.4619060158729553},{"id":"https://openalex.org/C2777844706","wikidata":"https://www.wikidata.org/wiki/Q422504","display_name":"Deoxycytidine","level":4,"score":0.4564493000507355},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.45536109805107117},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4410301446914673},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.43333643674850464},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4329673945903778},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3506026864051819},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32402652502059937},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.23358970880508423},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.10349678993225098},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.10054507851600647},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08957523107528687},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.07850077748298645},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.3547","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3547","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.3547","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2133124834","https://openalex.org/W2568189303","https://openalex.org/W2979658815","https://openalex.org/W1970772467","https://openalex.org/W2142364040","https://openalex.org/W2594750839","https://openalex.org/W2289844547","https://openalex.org/W2994328166","https://openalex.org/W2994542474","https://openalex.org/W2589164519"],"abstract_inverted_index":{"3547":[0],"Background:":[1],"5-AZA":[2,44,54,76,352,366],"is":[3,9,361],"a":[4,10,36],"DNA":[5,102,300],"hypomethylating":[6,18],"agent.":[7],"VPA":[8,46,62,354,370],"histone":[11,398],"deacetylase":[12],"inhibitor":[13],"(HDACI).":[14],"The":[15,188,349,363],"combination":[16,42,350,368],"of":[17,40,43,121,239,306,309,335,345,351,365],"agents":[19],"and":[20,28,45,82,119,126,157,175,183,209,246,253,271,295,328,353,383,397],"HDACI":[21],"has":[22],"synergistic":[23],"anticancer":[24],"activity":[25],"in":[26,29,47,91,111,217,285,304,343,355,367,390],"vitro":[27],"vivo.":[30],"Based":[31],"on":[32,89,116],"this,":[33],"we":[34],"conducted":[35],"phase":[37],"I":[38],"study":[39],"the":[41,92,107,240,307,336,346],"patients":[48,99,137,356],"with":[49,106,131,223,237,251,256,266,273,287,357,369],"advanced":[50,358],"solid":[51,359],"cancers.":[52],"Methods:":[53],"was":[55,63,77,104,129,142,190,215,282,302,316,341,371,388],"administered":[56],"SQ":[57,193,374],"daily":[58,66,194,375],"for":[59,195,231,244,261,278,376],"10":[60,120,196,326,377],"days.":[61,197,378],"given":[64],"orally":[65],"titrated":[67],"to":[68,321,330,406],"75\u2013100":[69],"mcg/ml.":[70],"Cycles":[71],"were":[72,138,186,380,400],"28":[73],"days":[74,117],"long.":[75],"started":[78],"at":[79,163,176],"20":[80],"mg/m2":[81,192,373],"escalated":[83],"using":[84],"an":[85],"adaptive":[86],"algorithm":[87],"based":[88],"toxicity":[90],"prior":[93],"cohort.":[94],"Each":[95],"cohort":[96],"included":[97,150,200],"6":[98,232,247],"(pts).":[100],"Global":[101,299],"methylation":[103,314],"estimated":[105],"LINE":[108,313],"pyrosequencing":[109],"assay":[110],"peripheral":[112],"blood":[113],"mononuclear":[114],"cells":[115],"1":[118,171,184,272],"each":[122],"cycle.":[123,338],"Histone":[124,339],"H3":[125],"H4":[127],"acetylation":[128,340,399],"assessed":[130],"western":[132],"blots.":[133],"Results:":[134],"Forty":[135],"seven":[136],"evaluable.":[139],"Median":[140,312],"age":[141],"60":[143],"years":[144],"(15\u201377).":[145],"5-":[146,310],"AZA":[147],"dose":[148],"levels":[149],"20,":[151],"25,":[152],"37.5,":[153],"47,":[154],"59,":[155],"75":[156,169,191,372],"94":[158,177],"mg/m2.":[159],"One":[160,221,249,264],"DLT":[161],"occurred":[162],"37.5":[164],"(Neutropenic":[165],"fever":[166,382],"(NF)).":[167],"At":[168],"mg/m2,":[170,178],"grade":[172],"3":[173,179],"NF":[174,182],"DLTs":[180,379],"(2":[181],"thrombocytopenia)":[185],"observed.":[187],"MTD":[189,364],"Other":[198],"toxicities":[199],"drowsiness":[201],"(N=6),":[202,204],"tremor":[203],"hypomagnesemia":[205],"(N=1),":[206],"anemia":[207],"(N=2)":[208,294],"vomiting":[210],"(N=1).":[211,298],"Stable":[212],"disease":[213],"(SD)":[214,387],"observed":[216,284,342,389],"16":[218,391],"pts":[219,236,255,286,392],"(34%).":[220,393],"pt":[222,250,265],"rapidly":[224],"progressive":[225],"renal":[226],"cell":[227],"carcinoma":[228,270,275],"had":[229,242,259,276],"SD":[230,243,260,277,281],"months":[233],"(mos).":[234],"Two":[235],"leiomyosarcoma":[238],"uterus":[241],"8":[245],"mos.":[248,263,280],"melanoma":[252,258],"two":[254],"uveal":[257],"4":[262,279],"sinus":[267],"adenoid":[268],"cystic":[269],"thymic":[274],"also":[283],"colon":[288],"(N=3),":[289],"sarcoma":[290],"(N=2),":[291],"papillary":[292],"thyroid":[293],"breast":[296],"cancer":[297],"hypomethylation":[301,396],"demonstrated":[303],"all":[305],"doses":[308],"AZA.":[311],"pretreatment":[315],"65%":[317],"(59\u201370%),":[318],"it":[319],"declined":[320],"61%":[322],"(53\u201363%)":[323],"by":[324,332],"day":[325,333],"(p=0.001)":[327],"returned":[329],"baseline":[331],"0":[334],"next":[337],"53%":[344],"pts.":[347],"Conclusions:":[348],"tumors":[360],"safe.":[362],"neutropenic":[381],"thrombocytopenia.":[384],"Clinical":[385],"benefit":[386],"Transient":[394],"global":[395],"demonstrated.":[401],"No":[402],"significant":[403],"financial":[404],"relationships":[405],"disclose.":[407]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}